Konstantinos Alataris - Net Worth and Insider Trading

Konstantinos Alataris Net Worth

The estimated net worth of Konstantinos Alataris is at least $0 dollars as of 2025-05-24. Konstantinos Alataris is the President, CEO of Zosano Pharma Corp and owns about 182 shares of Zosano Pharma Corp (ZSANQ) stock worth over $0. Details can be seen in Konstantinos Alataris's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Konstantinos Alataris has not made any transactions after 2016-08-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Konstantinos Alataris

To

Konstantinos Alataris Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Konstantinos Alataris owns 1 companies in total, including Zosano Pharma Corp (ZSANQ) .

Click here to see the complete history of Konstantinos Alataris’s form 4 insider trades.

Insider Ownership Summary of Konstantinos Alataris

Ticker Company Transaction Date Type of Owner
ZSANQ Zosano Pharma Corp 2016-08-19 President

Konstantinos Alataris Latest Holdings Summary

Konstantinos Alataris currently owns a total of 1 stock. Konstantinos Alataris owns 182 shares of Zosano Pharma Corp (ZSANQ) as of August 19, 2016, with a value of $0.

Latest Holdings of Konstantinos Alataris

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ZSANQ Zosano Pharma Corp 2016-08-19 182 0.00 0

Holding Weightings of Konstantinos Alataris


Konstantinos Alataris Form 4 Trading Tracker

According to the SEC Form 4 filings, Konstantinos Alataris has made a total of 0 transactions in Zosano Pharma Corp (ZSANQ) over the past 5 years. The most-recent trade in Zosano Pharma Corp is the acquisition of 182 shares on August 19, 2016, which cost Konstantinos Alataris around $168,153.

Insider Trading History of Konstantinos Alataris

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Konstantinos Alataris Trading Performance

GuruFocus tracks the stock performance after each of Konstantinos Alataris's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Konstantinos Alataris is -52.77%. GuruFocus also compares Konstantinos Alataris's trading performance to market benchmark return within the same time period. The performance of stocks bought by Konstantinos Alataris within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Konstantinos Alataris's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Konstantinos Alataris

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -40 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -37.95 LIMIT LIMIT LIMIT LIMIT LIMIT

Konstantinos Alataris Ownership Network

Ownership Network List of Konstantinos Alataris

No Data

Ownership Network Relation of Konstantinos Alataris

Insider Network Chart


Konstantinos Alataris Owned Company Details

What does Zosano Pharma Corp do?

Who are the key executives at Zosano Pharma Corp?

Konstantinos Alataris is the President of Zosano Pharma Corp. Other key executives at Zosano Pharma Corp include director & Chief Executive Officer Steven Lo , Chief Financial Officer Christine Matthews , and VP & Clinical Dev & Med Affairs Donald J Kellerman .

Zosano Pharma Corp (ZSANQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Zosano Pharma Corp (ZSANQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zosano Pharma Corp (ZSANQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Zosano Pharma Corp (ZSANQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Zosano Pharma Corp Insider Transactions

No Available Data

Konstantinos Alataris Mailing Address

Above is the net worth, insider trading, and ownership report for Konstantinos Alataris. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Konstantinos Alataris's mailing address is: Fremont Ca 94555.